Annual FCF
-$66.75 M
+$18.52 M+21.72%
31 December 2023
Summary:
Black Diamond Therapeutics annual free cash flow is currently -$66.75 million, with the most recent change of +$18.52 million (+21.72%) on 31 December 2023. During the last 3 years, it has fallen by -$14.46 million (-27.66%). BDTX annual FCF is now -2649.18% below its all-time high of -$2.43 million, reached on 31 December 2017.BDTX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$11.32 M
+$3.40 M+23.11%
30 September 2024
Summary:
Black Diamond Therapeutics quarterly free cash flow is currently -$11.32 million, with the most recent change of +$3.40 million (+23.11%) on 30 September 2024. Over the past year, it has increased by +$7.07 million (+38.45%). BDTX quarterly FCF is now -126.55% below its all-time high of -$5.00 million, reached on 30 June 2019.BDTX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$61.20 M
+$7.07 M+10.36%
30 September 2024
Summary:
Black Diamond Therapeutics TTM free cash flow is currently -$61.20 million, with the most recent change of +$7.07 million (+10.36%) on 30 September 2024. Over the past year, it has increased by +$13.53 million (+18.10%). BDTX TTM FCF is now -788.56% below its all-time high of -$6.89 million, reached on 31 March 2019.BDTX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BDTX Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +21.7% | +38.5% | +18.1% |
| 3 y3 years | -27.7% | +59.5% | +35.1% |
| 5 y5 years | -682.5% | -112.8% | -255.7% |
BDTX Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -27.7% | +35.1% | at high | +60.4% | at high | +42.8% |
| 5 y | 5 years | -682.5% | +35.1% | -112.8% | +60.4% | -255.7% | +42.8% |
| alltime | all time | -2649.2% | +35.1% | -126.5% | +60.4% | -788.6% | +42.8% |
Black Diamond Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$11.32 M(-23.1%) | -$61.20 M(-10.4%) |
| June 2024 | - | -$14.73 M(-30.5%) | -$68.28 M(+0.5%) |
| Mar 2024 | - | -$21.20 M(+51.9%) | -$67.92 M(+1.7%) |
| Dec 2023 | -$66.75 M(-21.7%) | -$13.96 M(-24.1%) | -$66.75 M(-10.7%) |
| Sept 2023 | - | -$18.39 M(+28.0%) | -$74.73 M(+2.6%) |
| June 2023 | - | -$14.37 M(-28.3%) | -$72.81 M(-5.1%) |
| Mar 2023 | - | -$20.03 M(-8.7%) | -$76.70 M(-10.1%) |
| Dec 2022 | -$85.27 M(-17.1%) | -$21.94 M(+33.2%) | -$85.27 M(-2.8%) |
| Sept 2022 | - | -$16.47 M(-9.8%) | -$87.71 M(-11.6%) |
| June 2022 | - | -$18.26 M(-36.2%) | -$99.22 M(-7.2%) |
| Mar 2022 | - | -$28.61 M(+17.3%) | -$106.97 M(+4.0%) |
| Dec 2021 | -$102.86 M | -$24.38 M(-12.8%) | -$102.86 M(+9.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$27.97 M(+7.5%) | -$94.36 M(+21.2%) |
| June 2021 | - | -$26.01 M(+6.2%) | -$77.89 M(+19.0%) |
| Mar 2021 | - | -$24.50 M(+54.2%) | -$65.46 M(+25.2%) |
| Dec 2020 | -$52.29 M(+111.7%) | -$15.88 M(+38.2%) | -$52.29 M(+19.1%) |
| Sept 2020 | - | -$11.49 M(-15.4%) | -$43.89 M(+16.4%) |
| June 2020 | - | -$13.59 M(+20.1%) | -$37.72 M(+29.5%) |
| Mar 2020 | - | -$11.32 M(+51.2%) | -$29.13 M(+17.9%) |
| Dec 2019 | -$24.70 M(+189.5%) | -$7.49 M(+40.7%) | -$24.70 M(+43.5%) |
| Sept 2019 | - | -$5.32 M(+6.5%) | -$17.21 M(+44.8%) |
| June 2019 | - | -$5.00 M(-27.4%) | -$11.89 M(+72.6%) |
| Mar 2019 | - | -$6.89 M | -$6.89 M |
| Dec 2018 | -$8.53 M(+251.3%) | - | - |
| Dec 2017 | -$2.43 M | - | - |
FAQ
- What is Black Diamond Therapeutics annual free cash flow?
- What is the all time high annual FCF for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics annual FCF year-on-year change?
- What is Black Diamond Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics quarterly FCF year-on-year change?
- What is Black Diamond Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics TTM FCF year-on-year change?
What is Black Diamond Therapeutics annual free cash flow?
The current annual FCF of BDTX is -$66.75 M
What is the all time high annual FCF for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high annual free cash flow is -$2.43 M
What is Black Diamond Therapeutics annual FCF year-on-year change?
Over the past year, BDTX annual free cash flow has changed by +$18.52 M (+21.72%)
What is Black Diamond Therapeutics quarterly free cash flow?
The current quarterly FCF of BDTX is -$11.32 M
What is the all time high quarterly FCF for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high quarterly free cash flow is -$5.00 M
What is Black Diamond Therapeutics quarterly FCF year-on-year change?
Over the past year, BDTX quarterly free cash flow has changed by +$7.07 M (+38.45%)
What is Black Diamond Therapeutics TTM free cash flow?
The current TTM FCF of BDTX is -$61.20 M
What is the all time high TTM FCF for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high TTM free cash flow is -$6.89 M
What is Black Diamond Therapeutics TTM FCF year-on-year change?
Over the past year, BDTX TTM free cash flow has changed by +$13.53 M (+18.10%)